The goal of this study is to find out if a rice-based version of the F-75 therapeutic food helps children with severe acute malnutrition (SAM) and persistent diarrhea recover better than the standard commercial F-75. The main questions it aims to answer are: 1. Does rice-based F-75 reduce the duration of diarrhea and improve nutritional recovery in children with SAM? 2. Is rice-based F-75 as safe and well-tolerated as the standard WHO F-75? Researchers will compare two groups: One group will receive the new rice-based F-75. The other group will receive the standard F-75. Participants will: 1. Be children aged 6 to 59 months admitted with SAM and persistent diarrhea 2. Be randomly assigned to one of the two feeding groups 3. Stay in a hospital ward for monitoring during the stabilization phase Be assessed daily for: Stool frequency Weight changes Appetite Medical problems or side effects This study will help determine whether the rice-based F-75 is a better option for malnourished children with diarrhea.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
stool frequency
Timeframe: day 1 to day 7 of starting therapeutic feed